Product Information
JANTOVEN 5 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.0888 per EA under NDC 00832121601. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 2, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832121601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
WARFARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040416FDA Approved
10/2/2003
TE Code
AB
On Market Since
2/23/2010
Pharmacological Classes
Price Statistics
The NADAC for JANTOVEN 5 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 18.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0888 per EA |
|---|---|
| All-time high | $0.2073 (Apr 15, 2015) |
| All-time low | $0.0751 (Nov 28, 2013) |
| 52-week high | $0.0994 |
| 52-week low | $0.0850 |
| Median price | $0.1054 |
| Average price | $0.1162 |
| Largest weekly change | +44.6% (Aug 20, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Warfarin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin K Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JANTOVEN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JANTOVEN 5 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.0888 per EA (NDC 00832121601), effective Sep 30, 2026.
How has the price of JANTOVEN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for JANTOVEN 5 MG TABLET has risen 18.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for JANTOVEN 5 MG TABLET?
Since Nov 28, 2013, the NADAC for JANTOVEN 5 MG TABLET has ranged from a low of $0.0751 (Nov 28, 2013) to a high of $0.2073 (Apr 15, 2015), with a median of $0.1054 per EA.
Are there cheaper alternatives to JANTOVEN 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as JANTOVEN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures JANTOVEN 5 MG TABLET?
JANTOVEN 5 MG TABLET (NDC 00832121601) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.